Results 151 to 160 of about 26,970,723 (329)

A large‐scale retrospective study in metastatic breast cancer patients using circulating tumour DNA and machine learning to predict treatment outcome and progression‐free survival

open access: yesMolecular Oncology, EarlyView.
There is an unmet need in metastatic breast cancer patients to monitor therapy response in real time. In this study, we show how a noninvasive and affordable strategy based on sequencing of plasma samples with longitudinal tracking of tumour fraction paired with a statistical model provides valuable information on treatment response in advance of the ...
Emma J. Beddowes   +20 more
wiley   +1 more source

Hawks\u27 Herald -- November 6, 2014 [PDF]

open access: yes, 2014
It is with regret that I announce the retirement of Comdr. Robert M. Laske after 7 years as Editor of the Naval War College Review. Commander Laske, more than any other individual, has been responsible for enhancing the stature of the Review as a ...
Roger Williams University
core   +4 more sources

Editorial: Innovation for Global and Local Impact (August 2019)

open access: yesTechnology Innovation Management Review, 2019
Stoyan Tanev, Gregory Sandstrom
doaj   +1 more source

Multidimensional OMICs reveal ARID1A orchestrated control of DNA damage, splicing, and cell cycle in normal‐like and malignant urothelial cells

open access: yesMolecular Oncology, EarlyView.
Loss of the frequently mutated chromatin remodeler ARID1A, a subunit of the SWI/SNF cBAF complex, results in less open chromatin, alternative splicing, and the failure to stop cells from progressing through the cell cycle after DNA damage in bladder (cancer) cells. Created in BioRender. Epigenetic regulators, such as the SWI/SNF complex, with important
Rebecca M. Schlösser   +11 more
wiley   +1 more source

REVIEWS [PDF]

open access: yesThe Mariner's Mirror, 1957
JOHN MUNDAY   +24 more
openaire   +2 more sources

MONTHLY REVIEW [PDF]

open access: bronze, 1927

openalex   +1 more source

ShcD adaptor protein drives invasion of triple negative breast cancer cells by aberrant activation of EGFR signaling

open access: yesMolecular Oncology, EarlyView.
We identified adaptor protein ShcD as upregulated in triple‐negative breast cancer and found its expression to be correlated with reduced patient survival and increased invasion in cell models. Using a proteomic screen, we identified novel ShcD binding partners involved in EGFR signaling pathways.
Hayley R. Lau   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy